Oncolytics Biotech Inc.

NASDAQ: ONCY · Real-Time Price · USD
1.08
0.14 (14.86%)
At close: Aug 15, 2025, 3:59 PM
1.05
-2.79%
After-hours: Aug 15, 2025, 07:06 PM EDT

Oncolytics Biotech Cash Flow Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-24.25M -24.46M -20.39M -20.78M -28.21M -27.75M -32.36M -26.84M -24.49M -24.84M -24.03M -24.5M -26.65M -26.3M -27.88M -29.76M -29.34M
Depreciation & Amortization
300.1K 326.1K 335.1K 333.1K 429K 403K 395.01K 389.83K 391.44K 392K 389.96K 376.67K 442.89K 452.06K 462.72K 487.97K 438.85K
Stock-Based Compensation
3.35M 2.72M 2.29M 2.59M 2.33M 2.07M 2.06M 1.81M 2.06M 2.38M 2.76M 3.26M 3.81M 3.83M 4.4M 3.6M 2.82M
Other Working Capital
2.52M 3.41M 5.28M 4.71M 2.66M 1.26M 2.21M -577.44K 120.64K 809.84K -1.19M -917.36K -968.31K -907.99K -234.8K -1.46M -1.09M
Other Non-Cash Items
-1.08M -1.15M -5.2M -4.97M -4.39M -4.31M -173.66K -1.5M -2.38M -1.68M -1.58M -302.69K 524.57K 91.73K 83.31K 73.69K 64.13K
Deferred Income Tax
n/a n/a -358K -1.06M -621K -621K -263K 444K n/a n/a 296.23K -909.19K -275.58K 408.56K 1.34M 2.84M 3.42M
Change in Working Capital
2.5M 3.32M 5.81M 5.17M 3.29M 1.76M 2.08M -780.89K -507.19K 391K -1.58M -1.17M -968.31K -907.99K -234.8K -1.46M -1.09M
Operating Cash Flow
-26M -26.97M -25.24M -26.44M -28.09M -28.45M -28.26M -26.48M -24.93M -23.36M -23.75M -23.24M -23.12M -22.43M -21.83M -24.22M -23.68M
Capital Expenditures
-38.16K -84.16K -81.16K -49.16K -49K -8K -4.26K -12.83K -24.48K -55K -130.45K -326.52K -321.47K -285.95K -211.24K -22.15K -18.59K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a -20.35M -20.35M -20.35M -20.35M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a 6.77M 13.56M 20.23M 20.23M 13.46M 6.67M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 6.77K 13.56K 20.23K -118 -6.88K -13.67K -20.35K n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-193K -239K -236K 6.56M 13.51M 20.22M -122.26K -6.9M -13.7M -20.4M -130.45K -326.52K -321.47K -285.95K -211.24K -22.15K -18.59K
Debt Repayment
-348K -348K -352K -374K -409K -407K -404.6K -398.6K -392.26K -380.26K -358.68K -337.95K -342.84K -365.51K -398.28K -437.84K -458.92K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -9.23K -9.23K -9.23K -9.23K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
2.1M 2.1M 2.48M 2.48M 781K 781K 405.76K 342.76K -242 11.76K 49.5K 54.33K 61.1K 469.4K 571.03K 566.2K 840.39K
Financial Cash Flow
11.03M 6.64M 5.04M 26.5M 28.22M 31.99M 36.12M 16M 12.46M 12.21M 6.28M 5.04M 12.86M 33.02M 44.51M 48.07M 46.7M
Net Cash Flow
-9.55M -13.21M -14.28M 13.43M 15.09M 23.59M 7.62M -16.17M -23.61M -29.6M -15.73M -17.11M -10.88M 10.04M 21.38M 20.89M 19.79M
Free Cash Flow
-19.22M -20.24M -18.51M -19.68M -28.14M -28.46M -28.27M -26.49M -24.96M -23.41M -23.88M -23.56M -23.44M -22.72M -22.04M -24.24M -23.7M